Prestige Consumer Healthcare (PBH) Other Preferred Equity (2012 - 2013)
Prestige Consumer Healthcare (PBH) recorded quarterly Other Preferred Equity of $283000.0 in Q4 2013, little changed quarter-over-quarter from $283000.0 in Q3 2013, and little changed on a YoY basis from $283000.0 in Q4 2012.
Prestige Consumer Healthcare (PBH) Other Preferred Equity (2012 - 2013) Analysis & Trends
Prestige Consumer Healthcare's Other Preferred Equity history runs 2 years deep, the most recent figure standing at $283000.0 for Q4 2013.
- In Q4 2013, Other Preferred Equity changed 0.0% year-over-year to $283000.0; the TTM figure through Dec 2013 stood at $283000.0 (changed 0.0% YoY), while the FY2013 annual figure was $283000.0, changed 0.0% from the prior year.
- Other Preferred Equity was $283000.0 for Q4 2013 at Prestige Consumer Healthcare, roughly flat from $283000.0 in the prior quarter.
- In the past five years, Other Preferred Equity ranged from a high of $283000.0 in Q1 2012 to a low of $283000.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 283,000.00 |
| Sep 30, 2013 | 283,000.00 |
| Jun 30, 2013 | 283,000.00 |
| Mar 31, 2013 | 283,000.00 |
| Dec 31, 2012 | 283,000.00 |
| Sep 30, 2012 | 283,000.00 |
| Jun 30, 2012 | 283,000.00 |
| Mar 31, 2012 | 283,000.00 |